Product Images Bupropion Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Bupropion Hydrochloride NDC 70377-034 by Biocon Pharma Inc.,, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Image - 47a33509 c700 4fb6 9da5 5c3bbf8d983d 01
image - 47a33509 c700 4fb6 9da5 5c3bbf8d983d 02
This is a package of Biocon extended-release tablets containing 150 mg of bupropion hydrochloride, a medication used to treat depression and smoking cessation. The warning advises not to use this medicine in combination with other medicines that contain bupropion hydrochloride. The package is child-resistant, and it is recommended to keep it out of reach of children. The medication guide should be provided separately to each patient, and the usual dosage is one tablet per day or as directed by the physician. The tablets should be stored at 20° to 25°C (68° to 77°F) and protected from light. This medication is manufactured by Graviti Pharmaceuticals Pvt. Ltd. in India and distributed by Biocon Pharma Inc. in the USA. This information is intended for prescription-only use.*
image - 47a33509 c700 4fb6 9da5 5c3bbf8d983d 03
Biocon Pharma Inc. manufactures bupropion hydrochloride extended-release tablets that come in a child-resistant package. The tablets contain 300 mg of bupropion hydrochloride USP and must be taken orally once daily or as prescribed by a physician, using the Medication Guide included in the package. The drug is used to treat depression, seasonal affective disorder, or smoking cessation, but should never be combined with Zyban or any other medication containing bupropion hydrochloride. They should be kept out of children's reach, and stored between 68° to 77°F, protecting them from light. Meanwhile, they were manufactured for Biocon Pharma in the US but were produced by Graviti Pharmaceuticals Pvt. Ltd. in Telangana, India. BPCMO0048/01 03011000084 was the Healthcare provider's form ID that provides medical information.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.